{"id":"https://openalex.org/W4282972071","doi":"https://doi.org/10.1158/1538-7445.am2022-1494","title":"Abstract 1494: 5-methyltetrahydrofolate (5-MTHF) as a superior ligand for delivery of small RNAs for cancer therapy","display_name":"Abstract 1494: 5-methyltetrahydrofolate (5-MTHF) as a superior ligand for delivery of small RNAs for cancer therapy","publication_year":2022,"publication_date":"2022-06-15","ids":{"openalex":"https://openalex.org/W4282972071","doi":"https://doi.org/10.1158/1538-7445.am2022-1494"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2022-1494","doi":"https://doi.org/10.1158/1538-7445.am2022-1494","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2022-1494","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023486659","display_name":"Kasireddy Sudarshan","orcid":"https://orcid.org/0000-0002-7072-3226","observed_orcids":["https://orcid.org/0000-0002-7072-3226"]},"institutions":[{"id":"https://openalex.org/I219193219","display_name":"Purdue University West Lafayette","ror":"https://ror.org/02dqehb95","country_code":"US","type":"education","lineage":["https://openalex.org/I219193219"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sudarsan R. Kasireddy","raw_affiliation_strings":["1Purdue University, West Lafayette, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Purdue University, West Lafayette, IN","institution_ids":["https://openalex.org/I219193219"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Ahmed M. Abdelaal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I219193219","display_name":"Purdue University West Lafayette","ror":"https://ror.org/02dqehb95","country_code":"US","type":"education","lineage":["https://openalex.org/I219193219"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ahmed M. Abdelaal","raw_affiliation_strings":["1Purdue University, West Lafayette, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Purdue University, West Lafayette, IN","institution_ids":["https://openalex.org/I219193219"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012446734","display_name":"Philip Stewart Low","orcid":"https://orcid.org/0000-0001-9042-5528","observed_orcids":["https://orcid.org/0000-0001-9042-5528"]},"institutions":[{"id":"https://openalex.org/I219193219","display_name":"Purdue University West Lafayette","ror":"https://ror.org/02dqehb95","country_code":"US","type":"education","lineage":["https://openalex.org/I219193219"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Philip S. Low","raw_affiliation_strings":["1Purdue University, West Lafayette, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Purdue University, West Lafayette, IN","institution_ids":["https://openalex.org/I219193219"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5082310628","display_name":"Andrea L. Kasinski","orcid":"https://orcid.org/0000-0002-9602-7827","observed_orcids":["https://orcid.org/0000-0002-9602-7827"]},"institutions":[{"id":"https://openalex.org/I219193219","display_name":"Purdue University West Lafayette","ror":"https://ror.org/02dqehb95","country_code":"US","type":"education","lineage":["https://openalex.org/I219193219"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrea L. Kasinski","raw_affiliation_strings":["1Purdue University, West Lafayette, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Purdue University, West Lafayette, IN","institution_ids":["https://openalex.org/I219193219"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I219193219"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"82","issue":"12_Supplement","first_page":"1494","last_page":"1494"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10062","display_name":"MicroRNA in disease regulation","score":0.0026000000070780516,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/5-methyltetrahydrofolate","display_name":"5-methyltetrahydrofolate","score":0.9990000128746033},{"id":"https://openalex.org/keywords/folate-receptor","display_name":"folate receptor","score":0.9539999961853027},{"id":"https://openalex.org/keywords/microrna-delivery","display_name":"microRNA delivery","score":0.7680000066757202},{"id":"https://openalex.org/keywords/microrna-mimics","display_name":"miRNA mimics","score":0.7009999752044678},{"id":"https://openalex.org/keywords/mir-34a","display_name":"miR-34a","score":0.9909999966621399},{"id":"https://openalex.org/keywords/endosomal-escape","display_name":"endosomal escape","score":0.7269999980926514},{"id":"https://openalex.org/keywords/nigericin","display_name":"nigericin","score":0.9959999918937683},{"id":"https://openalex.org/keywords/tumor-targeting","display_name":"tumor targeting","score":0.421999990940094},{"id":"https://openalex.org/keywords/cancer-therapy","display_name":"cancer therapy","score":0.5199999809265137},{"id":"https://openalex.org/keywords/myeloid-derived-suppressor-cells","display_name":"myeloid-derived suppressor cells","score":0.8529999852180481},{"id":"https://openalex.org/keywords/macrophages","display_name":"macrophages","score":0.8230000138282776}],"concepts":[{"id":"https://openalex.org/C145059251","wikidata":"https://www.wikidata.org/wiki/Q310899","display_name":"microRNA","level":3,"score":0.7394957542419434},{"id":"https://openalex.org/C2780306303","wikidata":"https://www.wikidata.org/wiki/Q24784504","display_name":"Folate receptor","level":4,"score":0.6875582933425903},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5413236021995544},{"id":"https://openalex.org/C102747710","wikidata":"https://www.wikidata.org/wiki/Q824237","display_name":"Endosome","level":3,"score":0.5288936495780945},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.5188614130020142},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4976697266101837},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4774887263774872},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.40095481276512146},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.38123196363449097},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3531856834888458},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3307257294654846},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2734370231628418},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.17742443084716797},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.10350695252418518}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2022-1494","doi":"https://doi.org/10.1158/1538-7445.am2022-1494","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2022-1494","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4409633283","https://openalex.org/W2740038310","https://openalex.org/W2742599023","https://openalex.org/W2742042163","https://openalex.org/W4362541636","https://openalex.org/W2887774956","https://openalex.org/W3132044115","https://openalex.org/W4290059248","https://openalex.org/W4409629247","https://openalex.org/W2135876321"],"abstract_inverted_index":{"Abstract":[0],"MicroRNAs":[1],"(miRNAs)":[2],"are":[3,62,80],"small":[4,278,320],"noncoding":[5],"RNAs":[6,321],"that":[7,61,79,113,146,167,179,199],"regulate":[8],"a":[9,110,116,162,314],"wide":[10],"array":[11],"of":[12,35,43,69,136,168,219,234,287,319,328],"genes.":[13],"Because":[14],"miRNA":[15,36,67,117],"downregulate":[16],"translation":[17],"proteins":[18],"associated":[19],"with":[20,223],"cancer":[21,323],"progression,":[22],"miRNA-based":[23],"therapeutics":[24],"have":[25],"great":[26],"potential":[27,34],"as":[28,239,313],"anticancer":[29],"drugs.":[30],"Nonetheless,":[31],"the":[32,55,88,120,128,134,140,151,159,191,205,217,224,244,273,295,329],"therapeutic":[33,66,252],"replacement":[37],"is":[38,68,92,171,202],"limited":[39],"due":[40],"to":[41,51,54,64,119,131,190,204,229],"lack":[42],"safe":[44],"and":[45,49,102,186,209,266],"efficient":[46],"delivery":[47,318],"vehicles,":[48],"inability":[50],"target":[52,83,211],"miRNAs":[53,237],"intended":[56],"cells/tissues.":[57],"Thus,":[58],"identifying":[59],"molecules":[60],"able":[63],"deliver":[65],"critical":[70],"need.":[71],"This":[72,241],"could":[73],"be":[74,292],"achieved":[75],"by":[76],"targeting":[77,255],"receptors":[78],"overexpressed":[81,93],"on":[82,94],"tumor":[84,96,193],"cells.":[85],"For":[86],"example,":[87],"folate":[89,125,142],"receptor":[90],"(FR)":[91],"various":[95],"types":[97],"including":[98,174,260],"breast,":[99],"lung,":[100],"ovarian":[101],"brain":[103],"tumors.":[104],"Our":[105,214],"laboratory":[106],"has":[107],"previously":[108],"developed":[109],"unique":[111],"strategy":[112],"directly":[114],"links":[115],"mimic":[118],"high":[121],"affinity":[122,149],"FR":[123,152,160,208,257],"ligand,":[124],"(FolamiRs).":[126],"In":[127],"present":[129],"work,":[130],"further":[132],"improve":[133],"potency":[135],"FolamiRs,":[137],"we":[138],"introduce":[139],"reduced":[141],"metabolite,":[143],"5-methyltetrahydrofolate":[144,311],"(5-MTHF)":[145,312],"maintains":[147],"nanomolar":[148],"for":[150,246,254,275,281,317,322,332],"at":[153,161],"pH":[154,165],"7,":[155],"but":[156],"disengages":[157],"from":[158],"significantly":[163],"higher":[164],"than":[166],"folate,":[169],"which":[170],"important":[172],"when":[173],"an":[175],"endosomal":[176,182,225],"escape":[177,226],"agent":[178],"typically":[180],"disrupts":[181],"acidification.":[183],"We":[184,197],"synthesize":[185],"conjugate":[187],"5-MTHF":[188,220],"ligand":[189,316],"potent":[192],"suppressor":[194,263],"miRNA-34a":[195],"(5-MTHF-miR-34a).":[196],"show":[198],"5-MTHF-miR-34a":[200],"uptake":[201],"specific":[203],"cells":[206,264],"overexpressing":[207],"represses":[210],"gene":[212],"expression.":[213],"data":[215],"supports":[216],"use":[218],"in":[221,294],"combination":[222],"agent,":[227],"nigericin,":[228],"achieve":[230],"robust":[231],"cytosolic":[232],"localization":[233],"therapeutically":[235],"relevant":[236],"such":[238],"miR-34a.":[240],"work":[242],"provides":[243],"foundation":[245],"future":[247],"studies":[248,270],"using":[249],"5-MTHF-":[250],"conjugated":[251],"agents":[253],"additional":[256],"expressing":[258],"cells,":[259],"myeloid":[261],"derived":[262],"(MDSCs)":[265],"macrophages.":[267],"Collectively":[268],"these":[269,288],"will":[271,291],"pave":[272],"way":[274],"developing":[276],"5-MTHF-based":[277],"RNA":[279],"conjugates":[280],"treating":[282],"FR-expressing":[283],"cancers.":[284],"The":[285],"details":[286],"intriguing":[289],"results":[290],"discussed":[293],"poster.":[296],"Citation":[297],"Format:":[298],"Sudarsan":[299],"R.":[300],"Kasireddy,":[301],"Ahmed":[302],"M.":[303],"Abdelaal,":[304],"Philip":[305],"S.":[306],"Low,":[307],"Andrea":[308],"L.":[309],"Kasinski.":[310],"superior":[315],"therapy":[324],"[abstract].":[325],"In:":[326],"Proceedings":[327],"American":[330],"Association":[331],"Cancer":[333,344],"Research":[334],"Annual":[335],"Meeting":[336],"2022;":[337],"2022":[338],"Apr":[339],"8-13.":[340],"Philadelphia":[341],"(PA):":[342],"AACR;":[343],"Res":[345],"2022;82(12_Suppl):Abstract":[346],"nr":[347],"1494.":[348]},"counts_by_year":[],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2022-06-17T00:00:00"}
